Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Cited by (739)

Items 701–739 of 739

  1. Identificação de peptídeos-alvo de anticorpos contra a proteína RBD do vírus SARS-CoV-2 em indivíduos convalescentes e vacinados
    Jamille Ramos de Oliveira · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  2. Additional file 3 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
    Chunyan Yi, Xiaoyu Sun, Yixiao Lin, Chenjian Gu, Longfei Ding, Lu, Xiao, Zhuo Ru Yang, Yaguang Zhang, Liyan Ma, Wangpeng Gu et al. · 2021 · Figshare
  3. Additional file 4 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
    Chunyan Yi, Xiaoyu Sun, Yixiao Lin, Chenjian Gu, Longfei Ding, Lu, Xiao, Zhuo Ru Yang, Yaguang Zhang, Liyan Ma, Wangpeng Gu et al. · 2021 · Figshare
  4. Additional file 2 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
    Chunyan Yi, Xiaoyu Sun, Yixiao Lin, Chenjian Gu, Longfei Ding, Lu, Xiao, Zhuo Ru Yang, Yaguang Zhang, Liyan Ma, Wangpeng Gu et al. · 2021 · Figshare
  5. SARS-CoV-2 spike trimer complexed with a durable neutralizing antibody 6C6 fab
    G. Clabaugh · 2023
  6. N121T and N121S substitutions on the SARS‐CoV‐2 spike protein impact on serum neutralization
    Van Thi Lo, Hyun A. Lim, Seong Sik Jang, Min Chan Kim, Alain Chrysler Chamfort, Ha Yeon Kim, Da-Young Mun, Min-Chang Kang, Han Byul Lee, Sunjoo Kim et al. · 2024 · Journal of Medical Virology
  7. Analysis of the impact of coronavirus infection on human health: epidemiological data, vaccination strategies, psychological aspect, consequences (literature review)
    L. Hrytsenko, Олена Дюжикова · 2024 · Medicine Today and Tomorrow
  8. HIV-1-Based SARS-CoV-2 Pseudotyped Virus to Determine Neutralizing Antibody Titers in Chile
    Aracelly Gaete-Argel, Mónica L. Acevedo, Daniel R. Henríquez, Ricardo Soto‐Rifo, Fernando Valiente‐Echeverría · 2024 · The Latin American studies book series
  9. Advancements in Structural Basis of Covalent Inhibitors Targeting SARS-CoV-2 Essential Proteins
    Israr Fatima, Fahad M. Alshabrmi, Faris F. Aba Alkhayl, Muhammad Qasim, Almera Shafqat, Sara Batool, Muhammad Tayyab Jawad, Muhammad Tahir ul Qamar, Abdur Rehman · 2025 · Current Medicinal Chemistry
  10. Studi Farmakovigilans Vaksinasi Booster Covid-19 Pada Masyarakat Di Desa Pujon Kalimantan Tengah
    Devi Norlita, Iwan Yuwindry, Saftia Aryzki, Melviani Melviani · 2024 · Journal Pharmaceutical Care and Sciences
  11. Structural prediction of chimeric immunogen candidates to elicit targeted antibodies against betacoronaviruses
    Jamel Simpson, Peter M. Kasson · 2025 · PLoS Computational Biology
  12. In vitro diagnostic immunoassays for SARS-CoV-2
    Sandeep Kumar Vashist, John H. T. Luong · 2025 · Elsevier eBooks
  13. SARS-CoV-2 variants circulating in West and Central Africa between 2020 and 2022: A retrospective study
    Romane Guilbaud, Almoustapha Issiaka Maiga, Abdoul–Salam Ouédraogo, Yacouba Sawadogo, Fabien Roch Niama, Oumar Ouchar Mahamat, Thomas d’Aquin Toni, Abakar K. Kabo, Pembé Issamou Mayengué, Félix Koukouikila-Koussounda et al. · 2026 · Journal of Infection and Public Health
  14. Considerations in Molecular Strain Typing for Bacteria, Fungi, and Viruses
    Scott Wesley Long · 2025
  15. The pan-variant potential of light: 425 nm light inactivates SARS-CoV-2 variants of concern and non-cytotoxic doses reduce viral titers in human airway epithelial cells
    Nathan Stasko, Leslee Arwood, Nicole Jandick, Derry Spragion, Rachel C. Roberts, Mónica Setién, Ibrahim Henson, Abigail Annas, M. Leslie Fulcher, Marisa Brotton et al. · 2025 · mSphere
  16. Population-level toggling of T cell immune escape at human leukocyte antigen anchor residues in SARS-CoV-2 Spike proteins, in an ethnically diverse population region
    Nobubelo Kwanele Ngandu, Burtram Clinton Fielding, Peter Van Heusden, Kuhle Mcinga, Kriheska Francis, Gordon W. Harkins · 2025 · PLoS Computational Biology
  17. Atomic Force Microscopy Characterization of the Interaction Between SARS-CoV-2 and ACE2
    Hongtao Gao, Jing Hou, Shuai Yuan, Yongliang Yang · 2025 · IEEE International Conference on Cyber Technology in Automation, Control, and Intelligent Systems
  18. Modeling the Mutational Effects on Biochemical Phenotypes of SARS-CoV-2 Using Molecular Fields
    Baifan Wang, Zhen Xi · 2025 · Biomolecules
  19. Additional file 3 of Chronic shedding of a SARS-CoV-2 Alpha variant in wastewater
    Michael J. Conway, Yang, Hannah, Lauren A. Revord, Michael P. Novay, Rachel J. Lee, Avery S. Ward, Jackson D. Abel, Maggie R. Williams, Rebecca Lynne Uzarski, Elizabeth Wheeler Alm · 2024 · Figshare
  20. Additional file 1 of Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
    Aidan M. Kirkham, Madeline Monaghan, Bailey, Adrian J. M., Risa Shorr, Manoj Mathew Lalu, Dean A. Fergusson, David Allan · 2021 · Figshare
  21. Additional file 2 of Chronic shedding of a SARS-CoV-2 Alpha variant in wastewater
    Michael J. Conway, Yang, Hannah, Lauren A. Revord, Michael P. Novay, Rachel J. Lee, Avery S. Ward, Jackson D. Abel, Maggie R. Williams, Rebecca Lynne Uzarski, Elizabeth Wheeler Alm · 2024 · Figshare
  22. Additional file 1 of Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
    Yi, Chunyan, Sun, Xiaoyu, Lin, Yixiao, Chenjian Gu, Longfei Ding, Lu, Xiao, Yang, Zhuo, Zhang, Yaguang, Ma, Liyan, Wangpeng Gu et al. · 2021 · Figshare
  23. Additional file 2 of Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
    Shuchen Feng, Gail Reid, Nina M. Clark, Harrington, Amanda, Susan L. Uprichard, Susan C. Baker · 2024 · Figshare
  24. Additional file 1 of Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies
    Shuchen Feng, Gail Reid, Nina M. Clark, Harrington, Amanda, Susan L. Uprichard, Susan C. Baker · 2024 · Figshare
  25. Additional file 2 of Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol
    Aidan M. Kirkham, Madeline Monaghan, Bailey, Adrian J. M., Risa Shorr, Manoj Mathew Lalu, Dean A. Fergusson, David Allan · 2021 · Figshare
  26. Additional file 1 of Chronic shedding of a SARS-CoV-2 Alpha variant in wastewater
    Michael J. Conway, Yang, Hannah, Lauren A. Revord, Michael P. Novay, Rachel J. Lee, Avery S. Ward, Jackson D. Abel, Maggie R. Williams, Rebecca Lynne Uzarski, Elizabeth Wheeler Alm · 2024 · Figshare
  27. Fluorescent-expressing Modified Vaccinia Ankara Encoding T7 RNA Polymerase
    Nathaniel D. Jackson, Mahmoud M. Bayoumi, Luis Martínez‐Sobrido · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Epidémiologie génomique des pathogènes au Sénégal : mycobacterium tuberculosis et SARS-CoV-2
    Abdou Padane · 2023 · theses.fr (ABES)
  29. The redesign of the molecular scaffold of viral ion channel blockers
    Balázs Zoltán Zsidó, Erzsébet Mernyák, Fanni Földes, Zoltán Kopasz, Krisztina Leiner, Mónika Madai, Brigitta Zana, Anett Kuczmog, Csaba Hetényi · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Fluorescent protein-expressing Modified Vaccinia Ankara encoding T7 RNA polymerase
    Nathaniel D. Jackson, Mahmoud M. Bayoumi, Himadri Nath, Luis Martínez‐Sobrido · 2026 · Journal of Virology
  31. Comparative proteomics of human naso-oropharyngeal swabs from COVID19 patients for identification of potential biomarker candidates
    Sabyasachi Bandyopadhyay, Megha Brijwal, Arhaan Haridas, Aashish Choudhary, Punit Kaur, Lalit Dar, Gururao Hariprasad · 2026 · Biochemistry and Biophysics Reports
  32. The Redesign of the Molecular Scaffold of Viral Ion Channel Blockers
    Balázs Zoltán Zsidó, Erzsébet Mernyák, Zoltán Kopasz, Fanni Földes, Krisztina Leiner, Mónika Madai, Brigitta Zana, Anett Kuczmog, Csaba Hetényi · 2026 · Computational and Structural Biotechnology Journal
  33. Not All Heroes Wear Capes—Some Just Glow: Exploring Carbon Dots as Nanoagents Against COVID-19
    Alexandra Karagianni, Adamantia Zourou, Aekkachai Tuekprakhon, Nadiya Boyar, Zania Stamataki, Konstantinos Kordatos · 2026 · Processes
  34. Antibody Affinity Maturation by Yeast Mating against a Diverse Antigen Library Enhances Antibody Resistance to Viral Mutations
    Ryan L. Hard, Young Su Ko, Jonathan Parkinson, Wei Wang · 2026 · ACS Pharmacology & Translational Science
  35. Germinal centre-driven maturation of B cell response to SARS-CoV-2 vaccination
    Ali H. Ellebedy · 2024 · ImmPort
  36. BindingDB Entry 50019248: Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective.
    BindingDB · 2024 · UC San Diego
  37. Reduced antibody activity against SARS-CoV-2 B.1.617.2 delta virus
    Michael Diamond · 2025 · ImmPort
  38. Nasally delivered interferon lambda protects mice against SARS-CoV-2 infection
    Yoshihiro Kawaoka · 2024 · ImmPort
  39. Protective activity of mRNA vaccines
    Florian Krammer · 2024 · ImmPort